Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REBOXETINE vs REGADENOSON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REBOXETINE vs REGADENOSON: Safety Overview

Metric REBOXETINE REGADENOSON
Total FAERS Reports 185 3,071
Deaths Reported 19 84
Death Rate 10.3% 2.7%
Hospitalizations 63 321
Average Patient Age 53.6 yrs 68.1 yrs
% Female Patients 62.7% 58.6%
FDA Approval Date N/A Apr 10, 2008
Manufacturer N/A Apotex Corp.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription